← All medicines
Ximluci 10 mg/mL solution for injection
Licence EU/1/22/1691/002 · Unknown
- Licence holder
- Stada Arzneimittel AG (all products →)
- Active substance
- Ranibizumab
- Dosage form
- Solution for injection
- Route of administration
- Intravitreal use
- ATC code
- S01LA04
- First authorised
- 09/11/2022
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Similar biological application (Article 10(4) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.